Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/6/2025

Referral Guidelines for Pseudotumor Cerebri (Idiopathic Intracranial Hypertension)

Initial Referral Pathway

  • Patients with suspected IIH should be referred to a neurologist as the primary specialist, with urgent referral within 2-4 weeks for most cases, or sooner if visual symptoms are severe, as recommended by the American Academy of Neurology 1, 2
  • The referral timeframe should be based on symptom severity, with options including 2-4 weeks for patients with mild to moderate symptoms, within 48 hours for patients who are unable to care for themselves but have help, and emergency admission for patients unable to care for themselves without help 1

Indications for Referral to Tertiary Neuroscience Center

  • Patients with diagnostic uncertainty despite initial evaluation, failure of first-line treatments, rapid clinical deterioration, or serious complications such as subdural hematoma with mass effect should be referred to a tertiary neuroscience center 1

Services Required at Specialist Centers

  • Specialist centers should provide neuroradiological investigations, including CT myelography and/or digital subtraction myelography, as well as specialist clinical expertise in IIH diagnosis and treatment 1
  • Multidisciplinary team meetings for complex cases and surgical expertise for CSF diversion procedures or optic nerve sheath fenestration when needed are also essential 1

Common Pitfalls in Specialist Referral

  • Failing to recognize fulminant IIH, which requires emergency referral, is a common pitfall, and atypical presentations of IIH may require more extensive investigation 1, 3
  • Overlooking the need for venography (CT or MR) to exclude cerebral sinus thrombosis is another potential pitfall 1, 4

Special Considerations

  • For IIH without papilledema, referral should still be to a neurologist, but surgical management is not routinely considered unless advised by experienced clinicians in a multidisciplinary setting, according to the American Academy of Neurology 2
  • Patients with IIH in ocular remission may still have ongoing headache morbidity requiring neurological management 1

REFERENCES

1

idiopathic intracranial hypertension: consensus guidelines on management. [LINK]

Journal of Neurology, Neurosurgery and Psychiatry, 2018

2

idiopathic intracranial hypertension: consensus guidelines on management. [LINK]

Journal of Neurology, Neurosurgery and Psychiatry, 2018

3

Idiopathic Intracranial Hypertension [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

4

Diagnosing Idiopathic Intracranial Hypertension (IIH) [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025